Himalaya Nutravedics India SME IPO is a book-built SME issue opening on September 22, 2026, and closing on September 24, 2026. The company operates in the Ayurvedic and nutraceutical segment and is proposed to list on the BSE SME platform.
Himalaya Nutravedics SME IPO – Key Details
| Particular | Details |
|---|---|
| Company Name | Himalaya Nutravedics India Limited |
| IPO Type | SME IPO |
| IPO Open Date | September 22, 2026 |
| IPO Close Date | September 24, 2026 |
| Price Band | ₹100 – ₹106 per share |
| Issue Size | ₹26.50 Crore |
| Issue Type | Fresh Issue |
| Lot Size | 1,200 Shares |
| Minimum Retail Application | 2 Lots / 2,400 Shares |
| Minimum Investment | ₹2,54,400 |
| Allotment Date | September 25, 2026 |
| Listing Date | September 29, 2026 |
| Listing Platform | BSE SME |
| Lead Manager | Nirbhay Capital Services Pvt. Ltd. |
| Registrar | KFin Technologies Ltd. |
The issue comprises approximately 24.996 lakh fresh shares and is intended to raise ₹26.50 crore at the upper price band.
About Himalaya Nutravedics India
Himalaya Nutravedics India Limited is a Hyderabad-based company operating in the pharmaceutical, Ayurvedic and nutraceutical space. Its business includes manufacturing, marketing and distribution of Ayurvedic and nutraceutical formulations. The company also undertakes third-party contract manufacturing for some products.
Its product categories include formulations such as softgel capsules, tablets, medicated oils, liquid orals and protein powders, with products addressing areas such as digestive health, immunity, metabolic health and pain management.
Himalaya Nutravedics IPO GMP Today
As of the latest available market data, the Himalaya Nutravedics IPO GMP is ₹0 on sources tracking the grey market. GMP is an unofficial indicator and can change frequently. It is not an official NSE/BSE price and should not be considered a guaranteed listing price.
Himalaya Nutravedics IPO Lot Size
The lot size is 1,200 shares. Retail investors need to apply for a minimum of 2 lots, or 2,400 shares.
At the upper price band of ₹106:
2,400 × ₹106 = ₹2,54,400
Therefore, the minimum retail application amount is ₹2,54,400.
Use of IPO Proceeds
According to the reported issue details, Himalaya Nutravedics plans to use the IPO proceeds mainly for:
- ₹13.75 crore – Working capital requirements
- ₹7.50 crore – Business development, branding and digital marketing
- Remaining amount – General corporate purposes and issue-related requirements
Himalaya Nutravedics IPO Important Dates
| Event | Date |
|---|---|
| IPO Opens | September 22, 2026 |
| IPO Closes | September 24, 2026 |
| Allotment | September 25, 2026 |
| Refund/Unblocking | September 28, 2026 |
| Demat Credit | September 28, 2026 |
| Listing | September 29, 2026 |
The dates are based on the currently published IPO schedule and may be subject to change.
Strengths
Integrated Multi-Dosage Manufacturing: The company has manufacturing capabilities across multiple dosage forms, including capsules, tablets, oils, liquid orals and powders. This allows it to cater to diverse product requirements across therapeutic categories.
Doctor Acceptance: The company markets its branded products through healthcare practitioners, with doctor acceptance supported by product performance rather than mass advertising. This provides an established channel for its branded product portfolio.
Long-Standing Relationships:Himalaya Nutravedics has established relationships with its suppliers and customers. These relationships support the company's procurement and sales operations.
Risk Factors
Dependence on Ayurvedic Products: Ayurvedic products accounted for 94.57%, 92.09% and 79.27% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. Any reduction in demand for these products could adversely affect the company's business and financial performance.
Customer Concentration: Revenue from the company's top 10 customers accounted for 81.24%, 86.97% and 84.19% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. Loss of relationships with key customers or delays or reductions in their orders could adversely affect the company's business, financial condition and cash flows.
Supplier Concentration: The company has historically derived, and may continue to derive, a significant portion of its supplies from its top 10 suppliers. Any disruption in these supplier relationships could affect the availability and procurement of required raw materials and other supplies.
Conclusion
The Himalaya Nutravedics SME IPO is a ₹26.50 crore fresh issue with a price band of ₹100–₹106 and a lot size of 1,200 shares. The company operates in the Ayurvedic and nutraceutical segment, while the IPO proceeds are primarily planned for working capital and business development. Investors should review the company's offer documents, financials, valuation and risk factors before making an investment decision.
Himalaya Nutravedics IPO FAQ
What is the Himalaya Nutravedics IPO date?
The IPO opens on September 22, 2026 and closes on September 24, 2026.
What is the Himalaya Nutravedics IPO price band?
The price band is ₹100 to ₹106 per share.
What is the Himalaya Nutravedics IPO lot size?
The lot size is 1,200 shares.
What is the minimum investment?
The minimum retail application is 2 lots, or 2,400 shares, requiring ₹2,54,400 at ₹106 per share.
What is Himalaya Nutravedics IPO GMP today?
The latest available tracked GMP is ₹0. GMP is unofficial and can change.
Where will Himalaya Nutravedics shares be listed?
The shares are proposed to be listed on the BSE SME platform.